DePuy Synthes parent company Johnson & Johnson reported $18.3 billion in fourth quarter net sales — relatively flat over the same time last year — but full year sales reached $74.3 million, a 4.2 percent increase over the same period last year.
Here are 10 things to know about the financial report:
1. J&J's worldwide medical device sales reached $27.5 billion last year, a 3.4 percent decrease over 2013. There was an operational decrease of 1.6 percent and a negative constant currency impact of 1.8 percent.
2. Domestic sales dropped 4.3 percent in the year, while international sales were only down 2.7 percent.
3. The company's broad portfolio of orthopedic products contributed significantly to operational growth.
4. The orthopedics sales in the United States grew 2.4 percent to reach $1.3 billion in the fourth quarter.
5. International sales for the orthopedics business decreased 4.1 percent to $1.1 billion in the forth quarter last year.
6. Worldwide orthopedics sales in the fourth quarter were down 0.6 percent to $2.4 billion.
7. For the full year, the international sales in orthopedics were up 1 percent to $4.4 billion.
8. The United States orthopedics sales were up 2.4 percent for the full year in 2014, reaching nearly $5.2 billion.
9. Full year worldwide orthopedics sales were up 1.7 percent to $9.6 billion.
10. Last June, Johnson & Johnson divested the ortho-clinical diagnostics business.